Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stent Mania US Style

Executive Summary

For the last couple of years, J&J has all but owned the US market for coronary stents, in the process creating an $800 million business with 90-95% market share. But now it's bracing for a host of competitors, including Guidant's much anticipated product.

Related Content

Carotid Stenting: Trials and Tribulations
Business & Technology Briefs (01/2007)
Beyond Drug-Coated Stents


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts